Nicholas Glover, CEO and President at ProNAi Therapeutics Inc (DNAI), sold 5,000 shares at $10.04 ($50K) on 2016-01-15, disclosed to the SEC on 2016-01-19.
Open-market sale of $50k DNAI by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.